Idoven is a pioneering company that has developed the world's first cardiology-as-a-service platform, leveraging artificial intelligence to enhance the capabilities of both cardiologists and non-cardiology clinicians in identifying, triaging, and diagnosing patients at scale. The company collaborates with notable partners such as AstraZeneca, Abbott, GE Healthcare, and Google, and is supported by prominent investors including Insight Partners and Northzone. Idoven has received multiple accolades for its innovative AI technology, including recognition from the European Innovation Council and CB Insights as one of the top 50 companies in Digital Health for 2023. With a focus on driving customer success and strategic partnerships, Idoven is positioned as a disruptive force in the HealthTech and AI sectors.